Act global: think reputational
This article was originally published in Scrip
Executive Summary
Remember when pharma was the enemy within the international healthcare community, around 10-12 years ago? The image then was of industry being dragged kicking towards cooperation via court cases over AIDS drugs in South Africa, of the Durban AIDS conference, and of tetchy wrangling at the World Trade Organization over IP rights giving developing countries better access to medicines.